Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
229.1 EUR | -0.82% | +59.42% | +31.55% |
Chart calendar Alnylam Pharmaceuticals, Inc.
Upcoming events on Alnylam Pharmaceuticals, Inc.
Past events on Alnylam Pharmaceuticals, Inc.
2024-06-24 08:00 am | HELIOS-B Phase 3 StudyResults Call |
2024-05-16 10:30 am | Annual General Meeting |
2024-05-02 08:30 am | Q1 2024 Earnings Call |
2024-05-02 08:00 am | Q1 2024 Earnings Release |
2024-04-07 07:00 pm | KARDIA-2 Phase 2 Study Results Call |
2024-03-25 01:00 pm | Canaccord Genuity Genetic Medicine for Generalists Conference |
2024-03-20 10:00 am | Stifel CNS Day |
2024-03-12 10:15 am | Barclays Global Healthcare Conference |
2024-03-05 09:10 am | TD Cowen Health Care Conference |
2024-02-15 08:30 am | Q4 2023 Earnings Call |
2024-02-15 08:00 am | Q4 2023 Earnings Release |
2024-01-08 12:45 pm | JPMorgan Healthcare Conference |
2023-12-13 08:30 am | R&D Day |
2023-11-29 09:30 am | Piper Sandler Healthcare Conference |
2023-11-14 09:45 am | Stifel Healthcare Conference |
2023-11-14 05:00 am | Jefferies London Healthcare Conference |
2023-11-02 08:30 am | Q3 2023 Earnings Call |
2023-11-02 08:00 am | Q3 2023 Earnings Release |
2023-10-24 | Clinical Trials on Alzheimers Disease Conference |
2023-10-09 08:30 am | ONPATTRO FDA Approval Call |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 220 221 -0.43% | 493 476 3.49% | 844 823 2.64% | 1 037 1 013 2.41% | 1 828 1 827 0.1% | 1 875 |
EBITDA Million USD | Released Forecast Spread | -885 -857 -3.28% | -794 -773 -2.74% | -661 -608 -8.65% | -741 -646 -14.71% | 0,00 -250 - | -322 |
EBIT Million USD | Released Forecast Spread | -939 -893 -5.24% | -828 -833 0.51% | -709 -665 -6.58% | -785 -813 3.38% | -282 -275 -2.6% | -374 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -885 -853 -3.84% | -856 -826 -3.59% | -852 -750 -13.68% | -1 127 -1 138 1% | -434 -437 0.72% | -466 |
Net income Million USD | Released Forecast Spread | -886 -860 -3.08% | -858 -832 -3.22% | -853 -758 -12.46% | -1 131 -1 156 2.16% | -440 -441 0.12% | -458 |
EPS USD | Released Forecast Spread | -8,11 -7,93 -2.21% | -7,46 -7,18 -3.86% | -7,20 -6,42 -12.12% | -9,30 -9,42 1.32% | -3,52 -3,53 0.29% | -3,58 |
Announcement Date | 06/02/20 | 11/02/21 | 10/02/22 | 23/02/23 | 15/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 213 243 -12.17% | 225 256 -12.2% | 264 292 -9.38% | 335 312 7.23% | 319 313 2.16% | 319 351 -9.08% | 751 395 90.22% | 440 442 -0.58% | 494 427 15.82% | 446 | 460 | 470 | 504 | 528 |
EBITDA Million USD | Released Forecast Spread | -137 -200 31.43% | -182 -206 11.98% | -247 -118 -110.59% | -174 -185 5.58% | -136 -204 33.36% | -217 -135 -60.01% | 227 -134 269.42% | -143 | -29,9 -123 75.76% | -115 | -79,7 | -56,9 | ||
EBIT Million USD | Released Forecast Spread | -147 -211 30.37% | -192 -173 -11.02% | -258 -195 -32.42% | -189 -221 14.57% | -150 -180 16.95% | -230 -136 -69.1% | 214 -165 229.79% | -116 -114 -2.24% | -43,4 -117 62.87% | -117 | -113 | -114 | -110 | -119 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -239 -234 -2.18% | -275 -206 -33.41% | -406 -224 -81.14% | -207 -266 22.17% | -172 -237 27.24% | -274 -162 -68.79% | 151 -206 173.12% | -138 -149 7.5% | -63,6 -133 52.26% | -139 | -141 | -141 | -131 | -146 |
Net income Million USD | Released Forecast Spread | -240 -235 -2.25% | -277 -205 -35.27% | -406 -221 -84.03% | -207 -234 11.5% | -174 -217 19.87% | -276 -168 -64.42% | 148 -184 180.46% | -138 -157 12.18% | -65,9 -140 53.05% | -138 | -137 | -143 | -133 | -148 |
EPS USD | Released Forecast Spread | -2,00 -1,90 -5.45% | -2,29 -1,64 -39.55% | -3,32 -1,81 -83.85% | -1,68 -1,93 12.92% | -1,40 -1,73 19.14% | -2,21 -1,42 -56.08% | 1,18 -1,47 180.25% | -1,10 -1,25 11.8% | -0,52 -1,15 54.62% | -1,10 | -1,06 | -1,08 | -0,96 | -0,94 |
Announcement Date | 28/04/22 | 28/07/22 | 27/10/22 | 23/02/23 | 04/05/23 | 03/08/23 | 02/11/23 | 15/02/24 | 02/05/24 | - | - | - | - | - |
2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
2024-07-26 01:00 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Alnylam Pharmaceuticals, Inc.
2024-06-07 02:57 am | POLARIS GROUP: May 2024 Sales and Revenue Release |
2024-05-29 04:01 pm | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ALNY Stock
- DUL Stock
- Calendar Alnylam Pharmaceuticals, Inc.